690 related articles for article (PubMed ID: 10492660)
1. Itraconazole and terbinafine in perspective. From petri dish to patient.
De Doncker P; Gupta AK
Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole and terbinafine in perspective: from petri dish to patient.
De Doncker P
J Eur Acad Dermatol Venereol; 1999 Sep; 12 Suppl 1():S10-6; discussion S17. PubMed ID: 10509936
[TBL] [Abstract][Full Text] [Related]
3. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
4. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Gupta AK; Ryder JE; Johnson AM
Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
[TBL] [Abstract][Full Text] [Related]
5. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
6. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
7. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Angello JT; Voytovich RM; Jan SA
Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
[TBL] [Abstract][Full Text] [Related]
8. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
[TBL] [Abstract][Full Text] [Related]
9. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK
Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049
[TBL] [Abstract][Full Text] [Related]
10. Safety of itraconazole pulse therapy for onychomycosis. An update.
De Doncker P; Gupta AK; Cel Rosso JQ; Daniel CR; Rosen T; Verspeelt J; Marynissen G; Meuleneers L; Moskovitz B; Jacko M; Shear N; Odom RB; Aly R; Scher RK; Elewski BE
Postgrad Med; 1999 Jul; Spec No():17-25. PubMed ID: 10492662
[TBL] [Abstract][Full Text] [Related]
11. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Ginter-Hanselmayer G; Weger W; Smolle J
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
[TBL] [Abstract][Full Text] [Related]
12. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
Del Rosso JQ
J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
[TBL] [Abstract][Full Text] [Related]
14. Management of onychomycosis in children.
Gupta AK; De Rosso JQ
Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
[TBL] [Abstract][Full Text] [Related]
15. Treating onychomycosis.
Rodgers P; Bassler M
Am Fam Physician; 2001 Feb; 63(4):663-72, 677-8. PubMed ID: 11237081
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections.
Cribier BJ; Bakshi R
Br J Dermatol; 2004 Mar; 150(3):414-20. PubMed ID: 15030322
[TBL] [Abstract][Full Text] [Related]
17. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
18. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
Gupta AK; Lynch LE; Kogan N; Cooper EA
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
[TBL] [Abstract][Full Text] [Related]
19. Onychomycosis: improved cure rates with itraconazole and terbinafine.
Harrell TK; Necomb WW; Replogle WH; King DS; Noble SL
J Am Board Fam Pract; 2000; 13(4):268-73. PubMed ID: 10933291
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Kejda J
Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]